Seragon Pharmaceuticals Director of Finance Salaries in Boulder | Comparably
Seragon Pharmaceuticals develops small-molecule drugs for the treatment of estrogen receptor dependent breast cancer. read more
EMPLOYEE
PARTICIPANTS
4
TOTAL
RATINGS
106

Seragon Pharmaceuticals Director of Finance Salaries in Boulder

The average Seragon Pharmaceuticals Director of Finance in Boulder earns an estimated $115,012 annually. Seragon Pharmaceuticals' Director of Finance compensation is $47,003 less than the US average for a Director of Finance.

In Boulder, The Finance Department at Seragon Pharmaceuticals earns $6,387 more on average than the Operations Department.

Last updated 5 years ago.

$30k
$74k
$117k
$159k
$350k
$600k
$115,012
Average Compensation
$115,012
avg. base

Director of Finance Salaries at Seragon Pharmaceuticals

In Boulder, Directors of Finance earn $19,862 more than Accounting Managers.

Accounting Manager
$95k*
Senior Accountant
$95k*
Business Analyst
$82k*
Financial Analyst
$76k*
Accountant
$69k*
* estimated salary

Compensation at Seragon Pharmaceuticals by Department

In Boulder, The Finance Department averages $6,387 more than the Operations Department, and $13,224 less than the Sales Department

Sales
$91,336 Avg. total comp.
+$13k
Finance
$78,112 Avg. total comp.
Operations
$71,725 Avg. total comp.
-$6k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to Seragon Pharmaceuticals reported making $176,135, while the average male Director of Finance at similar sized companies reported making $188,131.

Director of Finance Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Director of Finance at companies similar size to Seragon Pharmaceuticals reported making $193,239, while the average Native American Director of Finance at similar sized companies reported making $145,000.

How Directors of Finance at Seragon Pharmaceuticals Rate Their Compensation

The majority of Directors of Finance at Seragon Pharmaceuticals believe they're compensated fairly. 50% of Directors of Finance at Seragon Pharmaceuticals say they receive annual bonuses, and the majority (67%) are satisfied with their benefits. See more compensation ratings at Seragon Pharmaceuticals

×
Rate your company